Pancreatic Cancer Research

ResearcherNanjing University of Chinese MedicineActive in the last 2 years

Xiaoyu Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3376-5643; OpenAlex author ID A5043124191. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers

Papers 3

  1. Extracellular vesicles from obese visceral adipose promote pancreatic cancer development and resistance to immune checkpoint blockade therapy. Co-author DOI 10.1016/j.cmet.2025.10.015↗
  2. Targeting MXD1 sensitises pancreatic cancer to trametinib. Co-author DOI 10.1136/gutjnl-2024-333408↗
  3. MiR-200a Suppresses the Proliferation and Metastasis in Pancreatic Ductal Adenocarcinoma through Downregulation of DEK Gene. Co-author DOI 10.1016/j.tranon.2015.11.005↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ziming Chen · 2 shared papers, 2025 · strength 0.38
  2. Jian Zheng · 2 shared papers, 2025 · strength 0.38
  3. Lingxing Zeng · 2 shared papers, 2025 · strength 0.38
  4. Xudong Huang · 2 shared papers, 2025 · strength 0.38
  5. Jialiang Zhang · 2 shared papers, 2025 · strength 0.38
  6. Shaoping Zhang · 2 shared papers, 2025 · strength 0.38
  7. Zilan Xu · 2 shared papers, 2025 · strength 0.38
  8. Chunling Xue · 2 shared papers, 2025 · strength 0.38
  9. Dongxin Lin · 2 shared papers, 2025 · strength 0.38
  10. Xiaowei He · 1 shared paper, 2025 · strength 0.19
  11. Gang Li · 1 shared paper, 2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.